Selection of target mutation in rat gastrointestinal tract E. coli by minute dosage of enrofloxacin
Open Access
- 4 September 2014
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Microbiology
- Vol. 5, 468
Abstract
It has been suggested that bacterial resistance is selected within a mutation selection window of antibiotics. More recent studies showed that even extremely low concentration of antibiotic could select resistant bacteria in vitro. Yet little is known about the exact antibiotic concentration range that can effectively select for resistant organisms in animal gastrointestinal (GI) tract. In this study, the effect of different dosages of enrofloxacin on resistance and mutation development in rat GI tract E. coli was investigated by determining the number of resistant E. coli recoverable from rat fecal samples. Our data showed that high dose antibiotic treatment could effectively eliminate E. coli with single gyrA mutation in the early course of treatment, yet the eradication effects diminished upon prolonged treatment. Therapeutic and sub-therapeutic dose (1/10 and 1/100 of therapeutic doses) of enrofloxacin could effectively select for mutation in GI tract E. coli at the later course of enrofloxacin treatment and during the cessation periods. Surprisingly, very low dose of enrofloxacin (1/1000 therapeutic dose) could also select for mutation in GI tract E. coli at the later course of enrofloxacin treatment, only with slightly lower efficiency. No enrofloxacin-resistant E. coli could be selected at all test levels of enrofloxacin during long term treatment and the strength of antibiotic treatment does not alter the overall level of E. coli in rat GI tract. This study demonstrated that long term antibiotic treatment seems to be the major trigger for the development of target mutations in GI tract E. coli, which provided insight into the rational use of antibiotics in animal husbandry.Keywords
This publication has 30 references indexed in Scilit:
- Bacterial Resistance Studies Using In Vitro Dynamic Models: the Predictive Power of the Mutant Prevention and Minimum Inhibitory Antibiotic ConcentrationsAntimicrobial Agents and Chemotherapy, 2013
- Antibiotic Administration Routes Significantly Influence the Levels of Antibiotic Resistance in Gut MicrobiotaAntimicrobial Agents and Chemotherapy, 2013
- Starvation, Together with the SOS Response, Mediates High Biofilm-Specific Tolerance to the Fluoroquinolone OfloxacinPLOS Genetics, 2013
- Stress responses as determinants of antimicrobial resistance in Gram-negative bacteriaTrends in Microbiology, 2012
- Role of the Two Component Signal Transduction System CpxAR in Conferring Cefepime and Chloramphenicol Resistance in Klebsiella pneumoniae NTUH-K2044PLOS ONE, 2012
- Prevalence and characterisation of CTX-M β-lactamases amongst Escherichia coli isolates from healthy food animals in ChinaInternational Journal of Antimicrobial Agents, 2012
- In-feed antibiotic effects on the swine intestinal microbiomeProceedings of the National Academy of Sciences of the United States of America, 2012
- Food Animals and Antimicrobials: Impacts on Human HealthClinical Microbiology Reviews, 2011
- Selection of Resistant Bacteria at Very Low Antibiotic ConcentrationsPLOS Pathogens, 2011
- Prevalence and Dissemination of oqxAB in Escherichia coli Isolates from Animals, Farmworkers, and the EnvironmentAntimicrobial Agents and Chemotherapy, 2010